Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

the Novartis Vaccines Institute for Global Health (NVGH), part of the Novartis Institutes for BioMedical Research, has developed a typhoid vaccine with funding by the Fondazione Monte dei Paschi ...

SAN DIEGO (FOX 5/KUSI) — Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its ...

Novartis said it plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients, as well as open a second global biomedical research hub in San Diego. The company ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Dr. Roubenoff is Head of Global Translational Medicine for Musculoskeletal Diseases at Novartis Institutes for Biomedical Research. He has done pioneering work on the interactions of nutrition, ...

Sato, Vicki, Christoph Jaeker, and Pooja Mehta Solanki. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School ...

Novartis, a Swiss pharmaceutical company, announced a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure. The move ensures that all key Novartis ...

in Nutritional Sciences from Tufts University School of Nutrition. She is a Registered Dietitian and works on translational medicine at the Novartis Institutes for Biomedical Research. The Lupus ...

SAN DIEGO — Novartis, a Swiss pharmaceutical company ... According to the company, one of its biomedical research innovation hubs will be based in San Diego, and it will look to expand three ...